Morning Market Losers By: Benzinga via Benzinga June 01, 2015 at 10:25 AM EDT Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares dipped 24.44 percent to $27.70 after the company presented data from MGCD265 showing ... Read More >> Related Stocks: Celldex Therapeutics Clovis Oncology Inc Express Scripts Holding F5 Networks Mirati Therapeutics